Shopping Cart
Remove All
Your shopping cart is currently empty
CT-179
Copy Product Info
🥰Excellent
Catalog No. T70007Cas No. 1996636-69-1
Alias CT179
CT-179 is a potent and selective inhibitor of oligodendrocyte transcription factor 2 (OLIG2), reduces tumor cell proliferation and induces apoptosis, and enhances efficacy when used in combination with radiotherapy and other agents, showing potential in the treatment of medulloblastoma and glioblastoma.
CT-179
Copy Product Info🥰Excellent
Purity: 98.67%
Catalog No. T70007Alias CT179Cas No. 1996636-69-1
CT-179 is a potent and selective inhibitor of oligodendrocyte transcription factor 2 (OLIG2), reduces tumor cell proliferation and induces apoptosis, and enhances efficacy when used in combination with radiotherapy and other agents, showing potential in the treatment of medulloblastoma and glioblastoma.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $48 | In Stock | In Stock | |
| 5 mg | $113 | In Stock | In Stock | |
| 10 mg | $179 | In Stock | In Stock | |
| 25 mg | $328 | In Stock | In Stock | |
| 50 mg | $538 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $126 | In Stock | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:98.67%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | CT-179 is a potent and selective inhibitor of oligodendrocyte transcription factor 2 (OLIG2), reduces tumor cell proliferation and induces apoptosis, and enhances efficacy when used in combination with radiotherapy and other agents, showing potential in the treatment of medulloblastoma and glioblastoma. |
| In vitro | Methods: Daoy, UW228, and Med-813 MB cells were treated with CT-179 (0.01-10 μM, 7 days), and cell viability was determined by MTT assay. Results: CT-179 showed activity in all three cell lines, with IC50 values of 143.6 nM, 285.4 nM, and 985.2 nM, respectively. [1] |
| In vivo | Methods: CT-179 (50 mg/kg, ip, twice weekly for 2 weeks) was combined with RT (8 Gy, 2 Gy fractions) to treat immunocompromised NOD rag γ (NRG) mice implanted with orthotopic Daoy-luci (SHH-MB) to investigate whether it exhibits similar antitumor activity against human MB in vivo. Results: Animals treated with CT-179 + RT had significantly slower progression and significantly delayed tumor growth in the brain and spinal cord; CT-179 combined with RT significantly prolonged EFS. [1] |
| Synonyms | CT179 |
| Molecular Weight | 397.3 |
| Formula | C17H22Cl2N6O |
| Cas No. | 1996636-69-1 |
| Smiles | CN(C)CCCNc1cc(C)nc(NC(=O)Nc2ccc(Cl)c(Cl)c2)n1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy CT-179 | purchase CT-179 | CT-179 cost | order CT-179 | CT-179 chemical structure | CT-179 in vivo | CT-179 in vitro | CT-179 formula | CT-179 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.